title: CpG inclusion in feed reduces sea lice, Lepeophtheirus salmonis, numbers following re-infection.
abstract: Lepeophtheirus salmonis infections in Atlantic salmon, Salmo salar, have been characterized by little to no hyperplastic response and a biphasic immune response that results in chronic inflammation with tissue repair as the infection progresses. We hypothesized that CpG administration with prior lice exposure would enhance epithelial inflammatory mechanisms and boost the Atlantic salmon immune response to L. salmonis, leading to greater protection against infection. We administered multiple exposures of L. salmonis to two groups of Atlantic salmon and compared responses against first-time exposed Atlantic salmon. Following re-exposure, CpG fed fish exhibited increased skin expression of interleukin (IL)-1β and IL-12 β compared to control previously exposed (CPE) and control first-time exposed (CFE) animals, respectively. This inflammatory enhancement occurred with significantly lower expression of matrix metalloproteinase-9 (MMP 9), both systemically (spleen) and locally (skin). Reduced MMP 9 expression was a hallmark of the re-infected fish (occurred in both tissues at both times). When significant differences were present in the skin or spleen, the two re-exposed groups showed greater similarity than with the first exposure group. Lice numbers on CpG fed fish were significantly lower than CFE fish at 7 days post-re-infection (dpri), and although they were not significantly different at 17 dpri, the trend of lower lice levels remained. CpG fed fish also showed nearly twofold greater protection than CPE when compared to the CFE group (48.5% vs. 27.0% reductions at 7 dpri and 27.2% vs. 13.1% reductions at 17 dpri, respectively). The enhanced protection of CpG oligodeoxynucleotide administration to previous exposure was consistent across all body surfaces and suggests that CpG can not only enhance innate responses to L. salmonis in Atlantic salmon, but also further stimulate adaptive responses.
authors.affiliation: Hoplite Research Group, Department of Pathology and Microbiology, University of Prince Edward Island, Charlottetown, PE, Canada.
authors.forename: S L
authors.initials: SL
authors.lastname: Purcell
authors.forename: S E
authors.initials: SE
authors.lastname: Friend
authors.forename: J M
authors.initials: JM
authors.lastname: Covello
authors.forename: A
authors.initials: A
authors.lastname: Donkin
authors.forename: D B
authors.initials: DB
authors.lastname: Groman
authors.forename: J
authors.initials: J
authors.lastname: Poley
authors.forename: M D
authors.initials: MD
authors.lastname: Fast
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D033342:Copepoda / Q000502:physiology*; D004478:Ectoparasitic Infestations / Q000188:drug therapy / Q000662:veterinary*; D005393:Fish Diseases / Q000188:drug therapy*; D005786:Gene Expression Regulation / Q000187:drug effects; D007113:Immunity, Innate / Q000187:drug effects; D053762:Interleukin-12 Subunit p40 / Q000378:metabolism; D053583:Interleukin-1beta / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage*; D011156:Population Density; D012867:Skin / Q000187:drug effects
chemical_list: D000276:Adjuvants, Immunologic; D053762:Interleukin-12 Subunit p40; D053583:Interleukin-1beta; D009838:Oligodeoxyribonucleotides; D020780:Matrix Metalloproteinase 9